Monika Fischer, MD, reviewing Sandborn WJ, et al. Gastroenterology 2020 Feb 21. Upadacitinib, a selective Janus kinase 1 (Jak1) inhibitor (60-fold selective for Jak1 over
Jak1
Jak1
First Selective Oral Jak1 Inhibitor Induces Remission in Ulcerative Colitis
First Selective Oral Jak1 Inhibitor Induces Remission in Ulcerative Colitis
